These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33961152)

  • 21. Hereditary diffuse gastric cancer in a Japanese family with a large deletion involving CDH1.
    Yamada M; Fukagawa T; Nakajima T; Asada K; Sekine S; Yamashita S; Okochi-Takada E; Taniguchi H; Kushima R; Oda I; Saito Y; Ushijima T; Katai H
    Gastric Cancer; 2014 Oct; 17(4):750-6. PubMed ID: 24037103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future.
    van der Post RS; Gullo I; Oliveira C; Tang LH; Grabsch HI; O'Donovan M; Fitzgerald RC; van Krieken H; Carneiro F
    Adv Exp Med Biol; 2016; 908():371-91. PubMed ID: 27573781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological behavior of the intramucosal Helicobacter pylori-negative undifferentiated-type early gastric cancer: comparison with Helicobacter pylori-positive early gastric cancer.
    Horiuchi Y; Fujisaki J; Yamamoto N; Shimizu T; Miyamoto Y; Tomida H; Taniguchi C; Morishige K; Omae M; Ishiyama A; Yoshio T; Hirasawa T; Yamamoto Y; Tsuchida T; Igarashi M; Nakajima T; Takahashi H
    Gastric Cancer; 2016 Jan; 19(1):160-5. PubMed ID: 25491775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological and molecular characterization of early gastric adenocarcinoma in Helicobacter pylori-uninfected patients: emphasis on differentiated gastric adenocarcinoma.
    Akazawa Y; Ueyama H; Hayashi T; Utsunomiya H; Uchida R; Abe D; Oki S; Suzuki N; Ikeda A; Yatagai N; Komori H; Takeda T; Matsumoto K; Ueda K; Matsumoto K; Asaoka D; Hojo M; Saito T; Yao T; Nagahara A
    J Gastroenterol; 2022 Oct; 57(10):725-734. PubMed ID: 35939123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer.
    Adib E; El Zarif T; Nassar AH; Akl EW; Abou Alaiwi S; Mouhieddine TH; Esplin ED; Hatchell K; Nielsen SM; Rana HQ; Choueiri TK; Kwiatkowski DJ; Sonpavde G
    Br J Cancer; 2022 Mar; 126(5):797-803. PubMed ID: 34949788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies.
    Vos EL; Salo-Mullen EE; Tang LH; Schattner M; Yoon SS; Gerdes H; Markowitz AJ; Mandelker D; Janjigian Y; Offitt K; Coit DG; Stadler ZK; Strong VE
    JAMA Surg; 2020 Nov; 155(11):1050-1057. PubMed ID: 32997132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.
    Guilford P; Humar B; Blair V
    Gastric Cancer; 2010 Mar; 13(1):1-10. PubMed ID: 20373070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary Signet Ring Cell/Histiocytoid Carcinoma of the Eyelid: Somatic Mutations in
    Wang LC; Lin TC; Yeh YC; Ho HL; Tsai CC; Chou TY
    Curr Oncol; 2021 Feb; 28(1):918-927. PubMed ID: 33617508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary diffuse gastric cancer: a manifestation of lost cell polarity.
    Humar B; Guilford P
    Cancer Sci; 2009 Jul; 100(7):1151-7. PubMed ID: 19432899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic Laparoscopic Total Gastrectomy with Jejunal Pouch Reconstruction in Patients Carrying a CDH1 Germline Mutation.
    Haverkamp L; van der Sluis PC; Ausems MG; van der Horst S; Siersema PD; Ruurda JP; Offerhaus GJ; van Hillegersberg R
    J Gastrointest Surg; 2015 Dec; 19(12):2120-5. PubMed ID: 26443527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
    Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
    Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Case n(o) 6: Signet ring cell intramucosal carcinoma in hereditary diffuse gastric cancer with mutated CDH1 gene].
    Svrcek M
    Ann Pathol; 2011 Oct; 31(5):381-4. PubMed ID: 21982246
    [No Abstract]   [Full Text] [Related]  

  • 33. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members.
    Mayrbaeurl B; Keller G; Schauer W; Burgstaller S; Czompo M; Hoebling W; Knoflach P; Duba HC; Hoefler H; Thaler J
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):306-10. PubMed ID: 19474748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach.
    Caggiari L; Miolo G; Canzonieri V; De Zorzi M; Alessandrini L; Corona G; Cannizzaro R; Santeufemia DA; Cossu A; Buonadonna A; De Re V
    Cancer Biol Ther; 2018 Apr; 19(4):254-259. PubMed ID: 29131691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of E-cadherin and Runx3 in Helicobacter Pylori - Associated gastric carcinoma is achieved through regulating P21waf and P27 expression.
    Bahnassy AA; Helal TE; El-Ghazawy IM; Samaan GF; Galal El-Din MM; Abdellateif MS; Desouky E; Zekri AN
    Cancer Genet; 2018 Dec; 228-229():64-72. PubMed ID: 30553475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No mucosal escape of signet-ring cell carcinoma for ten years in a patient with familial aggregation of gastric cancer.
    Tanis PJ; Ten Kate FJ; van Lanschot JJ
    J Surg Oncol; 2008 Mar; 97(3):294-6. PubMed ID: 18161866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
    Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
    Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequent promoter methylation of CDH1 in non-neoplastic mucosa of sporadic diffuse gastric cancer.
    Lee KH; Hwang D; Kang KY; Lee S; Kim DY; Joo YE; Lee JH
    Anticancer Res; 2013 Sep; 33(9):3765-74. PubMed ID: 24023308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening.
    Carneiro F; Huntsman DG; Smyrk TC; Owen DA; Seruca R; Pharoah P; Caldas C; Sobrinho-Simões M
    J Pathol; 2004 Jun; 203(2):681-7. PubMed ID: 15141383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary gastric cancer.
    Carneiro F
    Pathologe; 2012 Nov; 33 Suppl 2():231-4. PubMed ID: 23052347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.